000			01954 a2200517 4500
005			20250518100414.0
264		0	_c20200720
008			202007s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0232055 _2doi
040			_aNLM _beng _cNLM
100	1		_aKurata, Atsuo
245	0	0	_aNovel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells. _h[electronic resource]
260			_bPloS one _c2020
300			_ae0232055 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAlbumins _xanalysis
650	0	4	_aAnimals
650	0	4	_aCell Line
650	0	4	_aCreatinine _xblood
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEpithelial-Mesenchymal Transition _xdrug effects
650	0	4	_aGene Expression Regulation _xdrug effects
650	0	4	_aGlomerulonephritis _xdrug therapy
650	0	4	_aHeterocyclic Compounds, 4 or More Rings _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aIntercellular Signaling Peptides and Proteins _xgenetics
650	0	4	_aKidney _xdrug effects
650	0	4	_aKidney Function Tests
650	0	4	_aKidney Tubules _xcytology
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aMolecular Structure
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aProto-Oncogene Proteins _xantagonists & inhibitors
650	0	4	_aRats
650	0	4	_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aTransforming Growth Factor beta1 _xgenetics
650	0	4	_aAxl Receptor Tyrosine Kinase
700	1		_aTachibana, Yukako
700	1		_aTakahashi, Tadakatsu
700	1		_aHoriba, Naoshi
773	0		_tPloS one _gvol. 15 _gno. 4 _gp. e0232055
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0232055 _zAvailable from publisher's website
999			_c30891153 _d30891153